COLLEDAN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 10.400
EU - Europa 7.711
AS - Asia 5.067
SA - Sud America 327
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 13
Totale 23.580
Nazione #
US - Stati Uniti d'America 10.239
SG - Singapore 2.588
IE - Irlanda 1.645
RU - Federazione Russa 1.631
HK - Hong Kong 1.615
IT - Italia 1.370
SE - Svezia 952
DE - Germania 901
CN - Cina 502
BR - Brasile 284
GB - Regno Unito 280
UA - Ucraina 253
CA - Canada 149
FR - Francia 134
FI - Finlandia 93
ID - Indonesia 92
NL - Olanda 88
IN - India 73
ES - Italia 68
BE - Belgio 55
AT - Austria 54
VN - Vietnam 47
CH - Svizzera 45
DK - Danimarca 42
TR - Turchia 24
EU - Europa 23
JP - Giappone 23
CZ - Repubblica Ceca 22
PT - Portogallo 19
EG - Egitto 14
KR - Corea 14
PL - Polonia 14
AR - Argentina 12
IR - Iran 12
UZ - Uzbekistan 12
RO - Romania 11
AU - Australia 9
EC - Ecuador 8
VE - Venezuela 7
IQ - Iraq 6
AZ - Azerbaigian 5
BD - Bangladesh 5
CL - Cile 5
GR - Grecia 5
MA - Marocco 5
PH - Filippine 5
RS - Serbia 5
TW - Taiwan 5
CO - Colombia 4
IL - Israele 4
MU - Mauritius 4
MX - Messico 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PE - Perù 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
PK - Pakistan 3
PS - Palestinian Territory 3
UY - Uruguay 3
ZA - Sudafrica 3
ZW - Zimbabwe 3
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ME - Montenegro 1
PA - Panama 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
UG - Uganda 1
Totale 23.580
Città #
Singapore 1.634
Hong Kong 1.607
Dublin 1.603
Ann Arbor 1.253
Princeton 817
Fairfield 659
New York 642
Frankfurt am Main 587
Chandler 586
Ashburn 539
Woodbridge 527
Santa Clara 483
Houston 399
Lawrence 385
Wilmington 341
Altamura 338
Seattle 255
Milan 242
Cambridge 207
Jacksonville 185
San Diego 139
Andover 117
Dearborn 111
Moscow 106
Shanghai 102
Toronto 93
Jakarta 89
Rome 70
Nuremberg 64
Nanjing 59
London 57
Helsinki 52
Beijing 49
Hangzhou 46
Boardman 42
Norwalk 34
Brussels 32
Guangzhou 32
Los Angeles 32
Lachine 30
Council Bluffs 27
Chicago 24
Pune 24
Vienna 23
Shenyang 22
Esslingen am Neckar 21
Falls Church 21
Kilburn 21
Fremont 20
Bergamo 19
São Paulo 19
Dong Ket 18
Florence 17
Siena 17
Turin 17
Boston 16
Zurich 16
Bologna 15
Ottawa 15
Tianjin 15
Utrecht 15
Atlanta 14
Naples 14
Valencia 14
Washington 14
Bari 13
Dallas 13
Rio de Janeiro 13
San Mateo 13
Manchester 12
Padova 12
Tashkent 12
Amsterdam 11
Barcelona 11
Genoa 11
Lappeenranta 11
Madrid 11
Philadelphia 11
Redmond 11
Azzano San Paolo 10
Lisbon 10
Lissone 10
Mountain View 10
Nanchang 10
Brasília 9
Changsha 9
Hebei 9
Jinan 9
Paris 9
Trumbull 9
Brescia 8
Chongqing 8
Cleveland 8
Garden City 8
Jiaxing 8
Modena 8
Olomouc 8
Reston 8
Belo Horizonte 7
Brno 7
Totale 15.450
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 482
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 310
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 257
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 253
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 229
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 211
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 202
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 199
Health Related Quality of Life in the Major Liver Conditions 193
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 192
Health related quality of life in chronic liver diseases 190
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 188
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 183
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 183
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 177
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 176
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 170
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 169
The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy 165
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 163
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 162
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 160
Delaying surgery for patients with a previous SARS-CoV-2 infection 160
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 158
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 156
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 152
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 151
Multicentre evaluation of case volume in minimally invasive hepatectomy 147
Trapianto intestinale 146
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 145
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 145
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 141
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 140
Extended right split liver graft for primary transplantation in children and adults. 139
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 136
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 135
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 133
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 131
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 128
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 128
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 126
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 125
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 122
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 122
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 122
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 120
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 120
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 117
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 116
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 115
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 112
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 110
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 107
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 107
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 105
null 102
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 101
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 101
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 99
A national mandatory-split liver policy: A report from the Italian experience 91
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 88
Liver transplantation in patients with B viral hepatitis and delta infection 86
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 85
Results of 24 orthotopic liver transplantation in Milan 85
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 84
The Activity of the Liver-Transplant Center of Milan, Italy 83
Liver Perfusion in Multiorgan Harvesting for Transplantation 83
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 81
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 81
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 80
Organ Procurement for Multivisceral Abdominal Transplantation in the Pig 78
Back-Table Surgery for Liver Grafts 77
Long-term results after liver transplantation in B and delta hepatitis 77
Pediatric liver transplantation: Indications, risk factors, and results 76
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 76
HEPATITIS-C VIRUS-INFECTION AND LIVER-TRANSPLANTATION 75
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 75
LIVER COLD-STORAGE USING UW SOLUTION - CLINICAL-RESULTS IN 23 CONSECUTIVE TRANSPLANTS 72
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 71
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 71
Induction of class I and class II major histocompatibility complex antigens (MHC) in rejecting human liver grafts 70
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 69
Liver transplants in children: The 8 years experience in Bergamo 68
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 67
B-Hepatitis and Liver-Transplantation 67
Full-Left Full-Right Split Liver Transplantation 66
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 66
BENCH RECONSTRUCTION OF THE GRAFT ARTERIAL SUPPLY IN LIVER-TRANSPLANTATION 65
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy 65
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 65
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 64
Patterns of hepatitis delta virus reinfection and disease in liver transplantation 64
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 64
Prolonged and repeated courses of OKT3 after liver transplantation 63
Results in 50 orthotopic liver transplants in Milan 62
Aspergillus Fumigatus infections in liver transplant patients 62
Life without notch: Liver repair in Alagille syndrome 62
DOES THE EXPERIENCE WITH LIVER-TRANSPLANTATION SUGGEST THAT HEPATITIS-DELTA VIRUS IS NOT CYTOPATHIC 61
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 60
Prevention of hepatitis B virus reinfection after liver transplantation 60
Totale 12.299
Categoria #
all - tutte 152.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 0 0 0 0 0 78 124 29
2020/20211.476 69 59 137 141 137 135 167 138 144 127 94 128
2021/20223.535 67 81 172 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/20257.951 647 1.854 488 490 1.059 272 500 338 1.693 610 0 0
Totale 25.019